Member Info for LTbeliever

Https://www.biospace.com/press-releases/celea-therapeutics-announces-180-million-financing-to-advance-deupirfenidone-as-a-potential-new-standard-of-care-to-treat-idiopathic-pulmonary-fibrosis-ipf

Wasn't Dan in Boston last week? Just kidding :)

FFX, no I don't have special vision glasses to see "invisible" partners, but logic suggests that Dan pocketed 1mln to outsource the studies (so, not much for him to do until the results are out), unless you are saying he pocketed 1mln to have fun? If so, he could have got on the plane and go to the May Conf. in Miami, for example. Or go to the World Cup for " meetings" with the invisible partners i.e. invisible meetings :))))

Yes he is part time because everything is O/sourced, there is no office etc. Funds raised 4 months ago, it must have taken some time to initiate the studies as well, so my guess (not inside info) is that the studies are still ongoing; once results are out, Dan will negotiate with partners and only then we may get an RNS; can't say when, but any time from now to September possibly? Maybe Soup can add more info?

I agree; it's a small team, with many different-size fish to fry; for maximum SP impact, better to get a juicy update; I still expect an update re the mineral. study and having new players (directly or indirectly get 6% in the fundraise, is another positive IMO.

This is counter-intuitive but, the longer they delay, the more optimistic I get! So many bad news over the years that nobody expects an RNS with positive news, that could actually turn the SP upwards; next week is my guess.

With hindsight, someone could argue that Dan 'd have waited a bit, before the fund raise, to sell the shares at a higher than 0.20p, and even do a Retail Offer instead of going to CMC cap in hand; however, the Iran war had just started and I think Dan was looking at the big picture i.e. pocket the money and get cracking with the add. data asked by the ("invisible" to some) partners.

Yes, CMC buying on own account and then trading down is highly probable; so, on the one hand, it's been keeping the SP down (in absence of progress), on the other hand, how could NFX have raised 1mln (that will - hopefully - see it through to a licensing deal) within 24 hours of the FDA ODD, when almost every PI here is too scared to invest more money? If in a few weeks time, the SP goes up 5-10x (If), will it matter that CMC was trading around the 0.20p?

U got your RNS Superdad, but only about a new Ins. Investor; still, someone has enough faith to buy 6% of IRON.

https://www.alvarfinancial.com/

IMO, with cash burn of appx 300-350k per month, a lot rests on what sales the Co has had so far and what it will have come September; in 2025 Sales were 1.7mln, when everything collapsed and licensees had still high stocks to sell; big unknown is, what were the sales in H1 2026 (we will know in September interims) and how much stock will need to be replenished in September by the new US rep?

If the Co makes Sales of eg 5mln this year, then it covers most of its o/heads, leaving a 3rd party that is interested, to provide funds (not necessarily a dilution) for the WSD4000 launch; of course, in the worst case scenario, Sales might still be too low and funds are not forthcoming, thus requiring a dilutory fund raise. As always, the devil will be in the details so either you speculate now, or sit back and wait for things to fall into place. DYOR, GLA

Just IMO, I am more inclined to trust SoupDragon, who owns 1% of the Co, and those who invested 1mln 4 months ago (even if speculators and/or short term investors), the Harry Kanes of this world, than those who lose their cool, kick the ball to waste time and give up before the 90 minutes are up.

Are we England or DRC? Summer is still not out, Dan will probably issue the RNS when everybody is at the beaches somewhere!

Either Dan doesn't care - "a part-timer" as the pessimists say - or, he expects things to fall into place in due course, hence he doesn't listen to people moaning. Take your pick and GLA.

Also, useful to remember from last November's Placing that "the New Ordinary Shares will represent approx 39.70 per cent. of the Company's issued ordinary share capital following Admission. The Issue Price of 1.75 pence per New Ordinary Share represents a discount of approx 22.2 per cent. to the closing mid-market price of 2.25 pence per Ordinary Share on 5 November 2025".

Thus, around half of holders are near B/even, almost a year after the Placing, so they have no incentive to sell at these price levels.

But no SP impact...yet.

Today is the last day for releasing the AFS of 2025; exactly 1 year ago we had a delay/suspension for a few weeks. Hope they release late afternoon.

https://www.lse.co.uk/rns/MET/publication-of-annual-report-accounts-9ebu3kjuq1er9ob.html

Good point N2M, a TR1 should follow soon; overhang clearing can only be a positive.

Though short-term uncertainty remains, 1) FUM now has better control of sales effort and marketing costs 2) risk of Haleon buying FUM for peanuts is gone, IMO.

IRON has been issuing updates (oper. and/or financial) every 1-2 months, over the past year or so, under the new CEO. 2-month mark is next week and there should already be at least 1 month's CF; it may be an exception to the rule but this time I think the "delay" will bring good news on at least the CFlow front; maybe even on the Miner/study too. GLA, just a few more days IMO.

U r probably right; normally, those chunky SELLS would either crash the SP, or the MM simply wouldn't execute them. Someone with big pockets?

I wouldn't bet for or against a deal RNS next week, but I will bet that the anti-PnD crusaders (2 to be exact) will show up here in the next hour or so :))

GLA.

Anyone sees any connection between REIN and NFX? I only found this about an IPF trial in the UK, last week or so - no NFX mention of any sort.

https://ir.reintx.com/news-releases/news-release-details/rein-therapeutics-expands-phase-2-renew-trial-united-kingdom

An order for both RHobbs and MediaMarkt were placed last Quarter so if they release some numbers, it could be significant news.

"its XF3 manufacturing partner Donlim, has received a Purchase Order from MediaMarkt, Europe's largest consumer electronics retailer for an initial production run of XF3 units."

https://www.lse.co.uk/rns/XSG/purchase-order-ahead-of-european-launch-of-xf3-jaivqxi8m5n2mqn.html

Yes, LOAM have to issue a TR 1 when they fall below 3%, but this could be some days/weeks after the event; at last TR1's issue they had 4.98% so they will issue at least 1 more (below 3%), or 2 max if they decide to sell below 4%, issue RNS and then wait a bit before selling below 3%.